Cristina Gervasoni

InstitutionASST Fatebenefratelli Sacco University Hospital
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 18 Covid-19 publications, with a maximum of 5 publications in November 2020
    All Publications
    Bar chart showing 121 publications over 27 distinct years, with a maximum of 13 publications in 2016 and 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tagliabue M, Ridolfo AL, Pina P, Rizzolo G, Belbusti S, Antinori S, Beltrami M, Cattaneo D, Gervasoni C. Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out. Prev Med Rep. 2021 Sep; 23:101471. PMID: 34221853.
    2. Cattaneo D, Pasina L, Conti F, Giacomelli A, Oreni L, Pezzati L, Bonazzetti C, Piscaglia M, Carrozzo G, Antinori S, Gervasoni C. Risks of potential drug-drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience. J Endocrinol Invest. 2021 Dec; 44(12):2849-2851. PMID: 34053008.
      Citations: 1     Fields:    Translation:Humans
    3. Cattaneo D, Corbellino M, Cozzi V, Fusi M, Gervasoni C. Comment on "Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6". Clin Pharmacokinet. 2021 06; 60(6):829-831. PMID: 33864625.
      Citations: 1     Fields:    Translation:Humans
    4. Cattaneo D, Pasina L, Maggioni AP, Maggioni AP, Oreni L, Conti F, Pezzati L, Casalini G, Bonazzetti C, Morena V, Ridolfo A, Antinori S, Gervasoni C. Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients. Drugs Aging. 2021 04; 38(4):341-346. PMID: 33646509.
      Citations:    Fields:    Translation:Humans
    5. Giacomelli A, Pagani G, Covizzi A, Antinori S, Cattaneo D, Gervasoni C. The importance of anamnesis in differential diagnosis: a case of SARS-CoV-2 and dengue virus co-infection. Infez Med. 2021 Mar 01; 29(1):114-116. PMID: 33664180.
      Citations:    Fields:    Translation:HumansCells
    6. Hoffmann C, Casado JL, Härter G, Vizcarra P, Moreno A, Cattaneo D, Meraviglia P, Spinner CD, Schabaz F, Grunwald S, Gervasoni C. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2021 05; 22(5):372-378. PMID: 33368966.
      Citations: 20     Fields:    Translation:HumansCells
    7. Andreotti F, Gervasoni C, Di Pasquale G, Maggioni AP. Methodological education in response to the quality of COVID-19 publications. Pharmacol Res. 2021 02; 164:105381. PMID: 33338624.
      Citations:    Fields:    Translation:Humans
    8. Cattaneo D, Corbellino M, Gervasoni C. Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts. Eur J Clin Pharmacol. 2021 05; 77(5):791-792. PMID: 33241457.
      Citations: 1     Fields:    Translation:Humans
    9. Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D, Atzori C, Ridolfo A, Cattaneo D. Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19. Clin Infect Dis. 2020 11 19; 71(16):2276-2278. PMID: 32407467.
      Citations: 69     Fields:    Translation:Humans
    10. Gervasoni C, Meraviglia P, Cattaneo D. Reply to Childs et al. Clin Infect Dis. 2020 11 05; 71(8):2023. PMID: 32459828.
      Citations: 1     Fields:    Translation:HumansCells
    11. Cattaneo D, Pasina L, Maggioni AP, Maggioni AP, Giacomelli A, Oreni L, Covizzi A, Bradanini L, Schiuma M, Antinori S, Ridolfo A, Gervasoni C. Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy. Drugs Aging. 2020 12; 37(12):925-933. PMID: 33150470.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    12. Di Pasquale G, Maggioni AP, Gervasoni C, Andreotti F. Trials and tribulations of coronavirus disease-2019 research: with a few bright lights in the fog. J Cardiovasc Med (Hagerstown). 2020 Nov; 21(11):841-844. PMID: 32858645.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    13. Giacomelli A, Pagani G, Ridolfo AL, Oreni L, Conti F, Pezzati L, Bradanini L, Casalini G, Bassoli C, Morena V, Passerini S, Rizzardini G, Cogliati C, Ceriani E, Colombo R, Rusconi S, Gervasoni C, Cattaneo D, Antinori S, Galli M. Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. J Med Virol. 2021 03; 93(3):1421-1427. PMID: 32776534.
      Citations: 5     Fields:    Translation:Humans
    14. Baldelli S, Corbellino M, Clementi E, Cattaneo D, Gervasoni C. Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose? J Antimicrob Chemother. 2020 09 01; 75(9):2704-2706. PMID: 32407513.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    15. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, Rusconi S, Gervasoni C, Ridolfo AL, Rizzardini G, Antinori S, Galli M. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 07 28; 71(15):889-890. PMID: 32215618.
      Citations: 441     Fields:    Translation:HumansCellsPHPublic Health
    16. Maggioni AP, Andreotti F, Gervasoni C, Di Pasquale G. COVID-19 trials in Italy: A call for simplicity, top standards and global pooling. Int J Cardiol. 2020 11 01; 318:160-164. PMID: 32610153.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    17. Cattaneo D, Cattaneo D, Gervasoni C, Corbellino M, Galli M, Riva A, Gervasoni C, Clementi E, Clementi E. Does lopinavir really inhibit SARS-CoV-2? Pharmacol Res. 2020 08; 158:104898. PMID: 32438034.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    18. Riva A, Conti F, Bernacchia D, Pezzati L, Sollima S, Merli S, Siano M, Lupo A, Rusconi S, Cattaneo D, Gervasoni C. Darunavir does not prevent SARS-CoV-2 infection in HIV patients. Pharmacol Res. 2020 07; 157:104826. PMID: 32325127.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    Gervasoni's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (221)
    Co-Authors (67)
    Similar People (60)